Orthopediatrics (KIDS) Getting Somewhat Favorable Press Coverage, Analysis Finds

News coverage about Orthopediatrics (NASDAQ:KIDS) has trended somewhat positive recently, according to Accern. The research firm rates the sentiment of media coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Orthopediatrics earned a news impact score of 0.03 on Accern’s scale. Accern also gave news headlines about the company an impact score of 46.5809673260258 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

A number of brokerages recently issued reports on KIDS. Zacks Investment Research lowered shares of Orthopediatrics from a “hold” rating to a “sell” rating in a report on Tuesday, January 9th. Piper Jaffray Companies began coverage on shares of Orthopediatrics in a report on Monday, November 6th. They set an “overweight” rating and a $24.00 price target for the company. BidaskClub lowered shares of Orthopediatrics from a “hold” rating to a “sell” rating in a report on Tuesday, January 9th. William Blair initiated coverage on shares of Orthopediatrics in a research note on Monday, November 6th. They issued an “outperform” rating for the company. Finally, BTIG Research initiated coverage on shares of Orthopediatrics in a research note on Monday, November 6th. They issued a “buy” rating and a $24.00 price objective for the company. Two equities research analysts have rated the stock with a sell rating and four have given a buy rating to the company’s stock. Orthopediatrics presently has an average rating of “Hold” and a consensus price target of $23.67.

Orthopediatrics (NASDAQ KIDS) traded down $0.06 during trading hours on Tuesday, hitting $19.10. 15,300 shares of the stock traded hands, compared to its average volume of 45,989. The company has a debt-to-equity ratio of -0.38, a current ratio of 2.78 and a quick ratio of 1.00. Orthopediatrics has a 12 month low of $17.03 and a 12 month high of $23.00.

Orthopediatrics (NASDAQ:KIDS) last released its quarterly earnings data on Wednesday, November 8th. The company reported ($1.70) earnings per share for the quarter, missing the consensus estimate of ($0.12) by ($1.58). analysts forecast that Orthopediatrics will post -1.41 EPS for the current fiscal year.

TRADEMARK VIOLATION WARNING: This story was first reported by Week Herald and is owned by of Week Herald. If you are accessing this story on another publication, it was illegally stolen and reposted in violation of US & international trademark & copyright laws. The legal version of this story can be viewed at https://weekherald.com/2018/01/16/orthopediatrics-kids-getting-somewhat-favorable-press-coverage-analysis-finds.html.

Orthopediatrics Company Profile

OrthoPediatrics Corp. is a United States-based medical device company. The Company designs, develops and commercializes orthopedic implants and instruments to meet the specialized needs of pediatric surgeons and their patients. It operates through the OrthoPediatrics segment, which designs, develops and markets implants and devices for children with orthopedic problems.

Insider Buying and Selling by Quarter for Orthopediatrics (NASDAQ:KIDS)

Receive News & Ratings for Orthopediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthopediatrics and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply